Can GSTP1 rs1695, vitamin D insufficiency, and zinc deficiency weaken thyroid antioxidant defense and immune tolerance?

Maintaining thyroid tissue homeostasis requires a delicate balance between robust antioxidant defenses and active immune tolerance. Genetic variations and micronutrient deficiencies can synergistically undermine these physiological protective barriers.

Clinical and physiological evidence

• Vitamin D insufficiency: Robust evidence links low vitamin D levels to compromised thyroidal immune tolerance, with Mendelian randomization and observational studies showing increased odds of autoimmune hypothyroidism and elevated thyroid-stimulating hormone (TSH) levels.
• GSTP1 rs1695 polymorphism: This genetic variant (Ile105Val) alters the catalytic activity of glutathione S-transferase P1, plausibly compromising glutathione-mediated detoxification under high metabolic stress.
• Zinc deficiency: As an essential cofactor, zinc deficiency biochemically impairs superoxide dismutase (SOD) enzyme activity and glutathione synthesis, representing a plausible pathway for increased oxidative stress in thyroid tissue.

Mechanistic pathways

• Breakdown of self-tolerance: Reduced antioxidant capacity leads to elevated oxidative stress in thyroid tissue, which promotes protein modifications and increases neo-antigen presentation. This process initiates the breakdown of self-tolerance.
• T-regulatory cell dysfunction: Vitamin D insufficiency directly impairs T-regulatory (Treg) cell function. When combined with oxidative neo-antigen generation, this double hit severely compromises localized immune tolerance and drives autoimmune thyroiditis pathways.

Bottom line

• Vitamin D insufficiency is a scientifically supported driver of thyroid immune dysfunction through altered T-regulatory cell activity, while the GSTP1 rs1695 variant and zinc deficiency are plausible contributors that weaken the localized antioxidant shield, collectively increasing susceptibility to thyroid autoimmunity.